These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3940518)

  • 1. Alleviation of induced vertigo. Therapy with transdermal scopolamine and oral meclizine.
    Schmitt LG; Shaw JE
    Arch Otolaryngol Head Neck Surg; 1986 Jan; 112(1):88-91. PubMed ID: 3940518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
    Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
    Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative investigation between thiethylperazine and meclizine in vertigo of different genesis.
    Jungert S
    Acta Otorhinolaryngol Belg; 1978; 32(3):264-72. PubMed ID: 360766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
    Patel PN; Ezzo DC
    Am J Health Syst Pharm; 2009 Nov; 66(22):2024-6. PubMed ID: 19890085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness.
    Pyykkö I; Schalén L; Jäntti V
    Acta Otolaryngol; 1985; 99(5-6):588-96. PubMed ID: 4024909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal scopolamine in the treatment of acute vertigo.
    Babin RW; Balkany TJ; Fee WE
    Ann Otol Rhinol Laryngol; 1984; 93(1 Pt 1):25-7. PubMed ID: 6703595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meclizine and placebo in treating vertigo of vestibular origin. Relative efficacy in a double-blind study.
    Cohen B; DeJong JM
    Arch Neurol; 1972 Aug; 27(2):129-35. PubMed ID: 4339240
    [No Abstract]   [Full Text] [Related]  

  • 8. Diazepam and Meclizine Are Equally Effective in the Treatment of Vertigo: An Emergency Department Randomized Double-Blind Placebo-Controlled Trial.
    Shih RD; Walsh B; Eskin B; Allegra J; Fiesseler FW; Salo D; Silverman M
    J Emerg Med; 2017 Jan; 52(1):23-27. PubMed ID: 27789115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal scopolamine for peripheral vertigo (a double-blind study).
    Rahko T; Karma P
    J Laryngol Otol; 1985 Jul; 99(7):653-6. PubMed ID: 3894551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Clissold SP; Heel RC
    Drugs; 1985 Mar; 29(3):189-207. PubMed ID: 3886352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z; Shupak A; Gordon CR
    Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy].
    Becker G; Goossens H; Seemann K; Souchon F; Weitz T
    Dtsch Med Wochenschr; 1984 Dec; 109(49):1881-5. PubMed ID: 6499689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The failure of antimotion sickness medication to improve reading in developmental dyslexia: results of a randomized trial.
    Fagan JE; Kaplan BJ; Raymond JE; Edgington ES
    J Dev Behav Pediatr; 1988 Dec; 9(6):359-66. PubMed ID: 3220956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
    Dornhoffer J; Chelonis JJ; Blake D
    Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to the dizzy patient.
    Baloh RW
    Baillieres Clin Neurol; 1994 Nov; 3(3):453-65. PubMed ID: 7874402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study.
    Reinhart DJ; Klein KW; Schroff E
    Anesth Analg; 1994 Aug; 79(2):281-4. PubMed ID: 7639364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines.
    Manning C; Scandale L; Manning EJ; Gengo FM
    J Clin Pharmacol; 1992 Nov; 32(11):996-1002. PubMed ID: 1474173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal scopolamine as a cause of transient psychosis in two elderly patients.
    Mego DM; Omori JM; Hanley JF
    South Med J; 1988 Mar; 81(3):394-5. PubMed ID: 3347867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of double-dose transdermal scopolamine.
    Bar R; Gil A; Tal D
    Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.